How is the APRI (AST-to-Platelet Ratio Index) calculated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

APRI Score Calculation

The APRI (AST-to-Platelet Ratio Index) is calculated using the formula: APRI = [(AST in IU/L / AST upper limit of normal in IU/L) / Platelet count in 10⁹/L] × 100 1.

Formula Components

The calculation requires three values:

  • AST level (aspartate aminotransferase in IU/L)
  • AST upper limit of normal (typically 40 IU/L, though this may vary by laboratory)
  • Platelet count (in 10⁹/L or expressed as ×10³/μL)

Simplified Calculation

When using the standard AST upper limit of normal of 40 IU/L, the formula simplifies to:

APRI = (AST / 40) / Platelet count × 100 1

Clinical Interpretation Thresholds

The APRI score is used to assess liver fibrosis severity in chronic liver disease, with established cutoff values 1:

For Significant Fibrosis (F2-F4):

  • APRI ≤0.5: High sensitivity (91%) for excluding significant fibrosis, though low specificity (47%)
  • APRI >1.5: High specificity (92-95%) for diagnosing significant fibrosis, though low sensitivity (39-41%)

For Cirrhosis (F4):

  • APRI ≤1.0: Sensitivity 89%, specificity 75% for excluding cirrhosis
  • APRI >2.0: Sensitivity 48-57%, specificity 93-94% for diagnosing cirrhosis

Important Clinical Caveats

APRI relies solely on AST and platelet count, making it susceptible to overestimation in specific clinical scenarios 1:

  • Acute hepatitis or intrahepatic inflammation: Elevated AST independent of fibrosis will artificially increase APRI
  • Hemolysis: Can falsely elevate AST levels
  • Thrombocytopenia from non-hepatic causes: Will artificially increase APRI (e.g., immune thrombocytopenia, bone marrow disorders)

Performance Characteristics

APRI demonstrates moderate diagnostic accuracy across chronic liver diseases 1:

  • Chronic Hepatitis C: AUC 0.77 for significant fibrosis, 0.83 for cirrhosis
  • Chronic Hepatitis B: AUC 0.72 for significant fibrosis, 0.76 for cirrhosis
  • NAFLD: Generally lower performance compared to viral hepatitis

FIB-4 has been shown to have superior diagnostic performance compared to APRI for detecting cirrhosis 2, 1, though both scores perform similarly for significant fibrosis.

Practical Application

Use APRI as a first-line, cost-free screening tool to stratify patients:

  • Low APRI (<0.5-1.0): Consider observation or repeat testing
  • Intermediate APRI: Proceed to additional testing (FIB-4, elastography, or biopsy)
  • High APRI (>1.5-2.0): Strong suspicion for advanced fibrosis; consider definitive testing or treatment initiation

APRI works best when combined with other noninvasive tests in sequential algorithms rather than used in isolation 2, 1.

References

Related Questions

Given an AST of 50 IU/L and a platelet count of 93,000/µL, what is the aspartate aminotransferase‑to‑platelet ratio index (APRI)?
What do a cerebrospinal fluid glucose of 112 mg/dL and protein of 30 mg/dL indicate?
In a patient with impaired concentration and a TSH of 12.3 mIU/L, what initial dose of levothyroxine (Synthroid) should be started?
What are the recent notable updates in medicine?
What antibiotic regimen should be used for a wound infection, including options for penicillin‑allergic patients and MRSA risk?
Can I take 600 mg of Caltrate (calcium carbonate) daily to correct a serum calcium of 7.8 mg/dL?
In a public health audit of a patient with schizoaffective disorder, which integrated neurological/medical therapy—such as an antibiotic, pharmacologic agent, biomedical, biotechnological, or bioinformatic approach—should be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.